All Eyes On China As Market Activity Heats Up
This article was originally published in PharmAsia News
Executive Summary
Mergers and acquisitions in China’s life sciences industry are ramping up, with some segments, such as the orthopedic device space, particularly hot. As Chinese companies rise with the market, alliance deals are increasing sharply and financing deals remain stable, according to EBI’s Strategic Transactions database.